Case Study – OneVoice™

Therapeutic Area: Immunology
PROGRAM OVERVIEW
SOLUTION
Program objectives:
- Ensure patients are motivated to start on therapy by delivering an exemplary experience
- Give patients the confidence and knowledge to start on therapy
- Provide ongoing support to patients on therapy, helping them to achieve long-term success
JOURNEY
12+ months, from onboarding to initiation to ongoing therapy management, personalized through predictive analytics and dynamic patient journey
ENROLLMENT
Initiated from the HUB, via API integration, website, SP and telephone line
CHANNELS
Omni-channel patient engagement, inclusive of telephony, live video, mail, email, and text
CLIENT MEASURED IMPACT ON ADHERENCE

At 30 Days:
Patients in VMS program had an 8% increase in persistency rate vs. non-VMS program patients.
At 360 Days:
Patients in VMS program had a 27% increase in persistency rate vs. non-VMS program patients.
Persistency rate is defined as the percentage of a cohort of patients (those who started the medication therapy at the same time) remain on therapy over time. It is the key quantitative measure of patient retention.
INNOVATION IN THE PROGRAM
“Thank you for providing more than just information. I know you care – you are my advocate and coach.”
—Patient
